Auto-generated from public data. Not the firm's stated position.
Based on disclosed data, Zühlke Ventures appears to focus on deep-tech and healthcare innovation across early to growth stages, with a particular emphasis on surgical robotics, drug delivery, and healthcare infrastructure. Recent portfolio companies suggest an investment thesis centered on medtech and biotech solutions that address clinical or operational inefficiencies. The firm's check size of €1.5M, €3.0M and multi-stage activity indicate a strategy of backing capital-intensive, science-driven ventures from seed through growth phases.
Generated 8 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Oct 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.